Stockhub

PharmaCyte Biotech, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 August 2022

13 August 2022

30 July 2022

  • curprev 21:2521:25, 30 July 2022‎ 172.18.0.2 talk‎ 1,208 bytes +1,208‎ Created page with "PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for panc..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/PharmaCyte_Biotech,_Inc.’